中国医药黑龙江有限公司
100-499人
公司优势
公司业务多元化,涵盖医疗配送、商业调拨、招商分销、医疗器械、基本药物配送等多个业态,其销售网络覆盖了整个黑龙江省,并辐射至吉林、辽宁、内蒙古、河北、山东、安徽、湖北等地区,拥有超过1000家下游客户。与超过600家国内外知名医药厂商建立了互利共赢的战略合作关系。
公司业务范围广泛,包括化学药制剂、中成药、抗生素、生化药品、生物制品、蛋白同化制剂、肽类激素、第二类精神药品制剂、麻醉药品、二、三类医疗器械等,常规经营品种达3000余种。
当前,公司下辖一家子公司,并积极筹划通过兼并收购、自建自营等方式,在全省区域中心城市增设子公司,以构建全面覆盖城乡的销售网络。
秉持“专业铸就品质、服务创造价值”的经营理念,公司致力于成为一家能够为客户创造价值、为员工提供成长平台、为股东带来回报的可信赖、受尊敬、行业领先的医疗健康供应链平台商。公司拥有一支高素质、高效率、充满激情和奉献精神的管理团队,以及一支充满活力、勇于创新、团结协作的员工队伍。
展望未来,公司将遵循党的十九大精神和习近平新时代中国特色社会主义思想,坚持创新发展理念,聚焦健康中国战略,不断推动行业进步,努力打造创新共赢平台,将公司建设成为医疗健康领域的卓越供应链平台商。

热招职位
相关职位
热门城市
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位,每周送达
🎉恭喜你,订阅成功
继续订阅您可以在邮箱中随时取消订阅
外卖式洗车,一键预约!
联峰集团是新加坡专注于前沿科技、网络、医疗、投资和地产的集团,与全球第二大医疗集团——IHH医疗集团为关系集团。联峰注重医疗品质,崇尚医德,签约合作的医生包括来自美国、中国、新加坡、台湾、马来西亚等著名国际医院各科的顶级专家以及国内三甲医院的一流专家。通过联峰国际远程医疗系统,可随时为您提供全球最领先的医疗技术和专家,进行全方位的健康管理和国际会诊。
谷城艺美家装饰
CStone Pharmaceuticals is an innovative, research-driven biopharmaceutical enterprise dedicated to pioneering the development of cutting-edge therapeutic medications. Situated in both Shanghai and Suzhou, the company boasts a leadership team comprised of experienced executives from leading multinational pharmaceutical corporations. In July 2016, CStone disclosed the successful conclusion of its Series A funding round, securing a total investment of $150 million (approximately 975 million RMB). This round was co-invested by three prominent industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).
With an unwavering commitment to addressing the critical healthcare needs of Chinese patients, CStone's extensive pipeline encompasses five therapeutic areas: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune disorders. The company's strategic focus on immuno-oncology serves as its cornerstone, aiming to propel Chinese research onto the global stage through its world-class research and development capabilities, an innovative drug portfolio, and an open innovation approach.
CStone Pharmaceuticals is a pioneering, research-focused biopharmaceutical company headquartered in Shanghai and Suzhou, China. Its executive team comprises seasoned professionals from top-tier multinational pharmaceutical firms. In July 2016, the company successfully concluded its Series A funding round, attracting a total investment of $150 million (equivalent to approximately 975 million RMB). This round was jointly supported by three distinguished industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).
Driven by a mission to meet the pressing medical needs of Chinese patients, CStone's comprehensive product pipeline spans across five therapeutic sectors: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune diseases. With immuno-oncology at the heart of its strategic focus, the company aspires to position Chinese research on the global stage, leveraging its world-class research and development expertise, innovative drug portfolio, and an open innovation philosophy.
山东电力设备厂是山东电力集团公司旗下的大型国有企业,其电站风机产品及备品配件等远销至印度、朝鲜、蒙古、孟加拉等国,年销售额超3亿元。该企业获国家质量学会、国家商品学会授予的全国同行业“优级品牌”称号,“辰明牌”电力变压器连续五年被评为“山东名牌”,并荣膺山东省“省级文明单位”称号及“山东省富民兴鲁劳动奖状”。企业具备完善的质量保障体系,于2003年通过国家级ISO9001质量、ISO14001环境管理体系双认证,同年还荣获“全国重合同守信用企业”称号。